|
Real-time Estimate
Cboe BZX
20:41:41 31/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.995 USD | -0.50% |
|
+4.06% | -22.68% |
| 08-12 | Aquestive Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-11 | Aquestive Therapeutics Q2 Loss Widens, Revenue Rises | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- AQST Stock
- Consensus Aquestive Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
